Survivors of childhood, adolescent, and young adult cancer, previously treated with
anthracycline chemotherapy (including mitoxantrone) or radiotherapy in which the heart was …

Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

The care for patients with cancer has advanced greatly over the past decades. A
combination of earlier cancer diagnosis and greater use of traditional and new systemic …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Objectives: This study sought to evaluate the efficacy of enalapril and carvedilol to prevent
chemotherapy-induced left ventricular systolic dysfunction (LVSD) in patients with …

Advances in cancer therapy have resulted in significant improvement in long-term survival
for many types of cancer but have also resulted in untoward side effects associated with …

1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

Objectives: The purpose of this study was to evaluate the clinical relevance of anthracycline-
induced cardiomyopathy (AC-CMP) and its response to heart failure (HF) therapy …

Cardiac dysfunction resulting from exposure to cancer therapeutics was first recognized in
the 1960s, with the widespread introduction of anthracyclines into the oncological …